This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...

Breakthroughs in age-related macular degeneration (AMD) treatments have revolutionized the management of this progressive and potentially devastating eye disease. These include treatments such as ...

In eyes with central IRF, BCVA changed -2.1 for the PDS group and -6.9 for the monthly group. These results highlight the effects of PDS treatment on stabilizing retinal anatomy and minimizing retinal ...

(RTTNews) - EyePoint Pharmaceuticals, Inc. (EYPT), Wednesday announced positive six-month results from the ongoing Phase 2 VERONA clinical trial, evaluating Duravyu for the treatment of diabetic ...

In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the ...

[14] The aim of this review is to summarize the current knowledge on disorders related to the vitreomacular interface with focus on vitreomacular adhesion and macular hole. The anatomy and ...

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) fell 21% today, diverging from the company's recent ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...